Quest Diagnostics profit slips 11% on slow demand for non-COVID tests By Reuters

admin October 21, 2021

0 15 1 minute read

(Reuters) – U.S. lab Quest Diagnostics (NYSE:INC) on Thursday reported an 11% drop in third-quarter profit as the spread of a highly contagious variable delta impacted demand for companies unaffected by the coronavirus.

Net income attributable to the company fell to $505 million, or $4.02 per share, in the quarter ended September 30, from $568 million, or $4.14 per share, a year earlier.

Disclaimer: Fusion Media I would like to remind you that the data on this website is not necessarily current or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges but by market makers, and therefore prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for trading purposes. Therefore Fusion Media assumes no responsibility for any business losses you may incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media shall have no liability for loss or damage as a result of reliance on the information including statements, quotes, charts and buy/sell signals included on this website. Please be fully aware of the risks and costs associated with trading in the financial markets, it is one of the riskiest forms of investment.

Source link

admin Send an email October 21, 2021
0 15 1 minute read

Facebook Twitter LinkedIn Tumblr Pinterest Reddit VKontakte Odnoklassniki Pocket

Share
Facebook Twitter LinkedIn Tumblr Pinterest Reddit VKontakte Odnoklassniki Pocket Share via Email Print